The 4 analysts offering 12-month price forecasts for Anavex Life Sciences Corp have a median target of 21.00, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a +86.01% increase from the last price of 11.29.
The current consensus among 4 polled investment analysts is to Buy stock in Anavex Life Sciences Corp. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.13
Reporting Date May 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.